lunes, 15 de septiembre de 2014

Genetic/Familial high-risk assessment... [J Natl Compr Canc Netw. 2014] - PubMed - NCBI

Genetic/Familial high-risk assessment... [J Natl Compr Canc Netw. 2014] - PubMed - NCBI



 2014 Sep;12(9):1326-38.

Genetic/Familial high-risk assessment: breast and ovarian, version 1.2014.

Abstract

During the past few years, several genetic aberrations that may contribute to increased risks for development of breast and/or ovarian cancers have been identified. The NCCN Guidelines for Genetic/Familial High-Risk Assessment: Breast and Ovarian focus specifically on the assessment of genetic mutations in BRCA1/BRCA2, TP53, and PTEN, and recommend approaches to genetic testing/counseling and management strategies in individuals with these mutations. This portion of the NCCN Guidelines includes recommendations regarding diagnostic criteria and management of patients with Cowden Syndrome/PTEN hamartoma tumor syndrome.
Copyright © 2014 by the National Comprehensive Cancer Network.

PMID:
 
25190698
 
[PubMed - in process]

No hay comentarios:

Publicar un comentario